ArticleNuclear medicine and molecular imaging2022

Interval Changes in PSMA PET/CT During Radium-223 Therapy for Metastatic Bone Disease from Castration-Resistant Prostate Cancer.

Stephan Probst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.